Literature DB >> 3258485

Perilymph fistula: the Stanford experience.

C Shelton1, F B Simmons.   

Abstract

Seventy-eight tympanotomies were performed to determine the presence of perilymph fistulas (PLFs); of these, 51% were found. The oval and round windows of all patients were grafted, whether PLFs were present or not. Of those patients with PLFs, 64% had resolution of their major symptom; when no PLF was found, 44% had a similar outcome. We concluded that 1) PLFs often behave as if they are epiphenomena in relation to hearing and balance, 2) PLFs can be intermittent, 3) PLF surgery is disappointing for restoration of hearing in sudden hearing loss when compared to the rate of spontaneous recovery, 4) stabilizing a fluctuating or progressive loss is a more realistic goal, and 5) establishing preoperative criteria for exploration is still a problem.

Entities:  

Mesh:

Year:  1988        PMID: 3258485     DOI: 10.1177/000348948809700201

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  5 in total

1.  Perilymph fistula: fifty years of controversy.

Authors:  Jeremy Hornibrook
Journal:  ISRN Otolaryngol       Date:  2012-07-31

2.  A balance test for chronic perilymph fistula.

Authors:  Jeremy Hornibrook
Journal:  Int J Otolaryngol       Date:  2012-09-18

3.  Critical evaluation of round window membrane sealing in the treatment of idiopathic sudden unilateral hearing loss.

Authors:  Stephan Hoch; Thomas Vomhof; Afshin Teymoortash
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-02-03       Impact factor: 3.372

Review 4.  Recent surgical options for vestibular vertigo.

Authors:  Stefan Volkenstein; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

Review 5.  Perilymphatic Fistula: A Review of Classification, Etiology, Diagnosis, and Treatment.

Authors:  Brooke Sarna; Mehdi Abouzari; Catherine Merna; Shahrnaz Jamshidi; Tina Saber; Hamid R Djalilian
Journal:  Front Neurol       Date:  2020-09-15       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.